People · Operator
Named in public records as an officer, director or promoter · active 2013–2018 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. | — | Biotechnology | Series C | $178.6M | $433.3M | 2016 |
| Biotie Therapies Corp. | — | Pharmaceuticals | Series D+ | $149.8M | $214.0M | 2015 |
| Semnur Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $6.0M | $185.8M | 2013 |
Mahendra G. Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mahendra G. Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edgar G Engleman | 2 | 5 |
| James Healy | 1 | 8 |
| Richard Miller | 1 | 8 |
| Peter Moldt | 1 | 6 |
| DAVID COOK | 1 | 5 |
| Mahendra Shah | 1 | 5 |
| William Burns | 1 | 3 |
| Guido Magni | 1 | 3 |
| Ashish Khanna | 1 | 3 |
| Reiner Laus | 1 | 2 |
| Kathleen LaPorte | 1 | 2 |
| Randall Schatzman | 1 | 2 |
| David Dornan | 1 | 2 |
| ISMAIL KOLA | 1 | 2 |
| Ian Massey | 1 | 2 |
| William Quinn | 1 | 2 |
| Chih-Ping Liu | 1 | 2 |
| Ashish G. Khanna | 1 | 2 |
| Peter Fellner | 1 | 1 |
| Peter G. Bisgaard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.